PACE-C Trial Results: SBRT vs Moderate Hypofractionation for High-Risk Prostate Cancer - Alison Tree
Alison Tree
Zachary Klaassen interviews Alison Tree about the PACE-C trial, comparing moderate hypofractionation to stereotactic body radiotherapy (SBRT) in unfavorable and high-risk prostate cancer patients.
Patient Perspectives on Bladder Cancer: Balancing Treatment Options and Shared Decision-Making - Roger Li
Roger Li
Roger Li discusses findings from a patient panel at the BCAN Think Tank, focusing on decision-making in BCG-unresponsive and muscle-invasive bladder cancer treatment.
